Therapy News and Research

RSS

National study sheds light on how to more effectively treat atrial fibrillation

A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem associated with increased risk of stroke and heart failure.

7 Nov 2022

Study helps to justify the use of Ayres Sensory Integration as a tool for autistic children

People with autism are often portrayed in popular media as experiencing difficulty processing highly stimulating or overly loud environments.

7 Nov 2022

High-intensity treatment strategy for heart failure reduces the risk of death or hospital readmission

Ramping up medication doses quickly after being hospitalized for acute heart failure resulted in a lower risk of dying or being readmitted for heart failure within the first six months after discharge, compared to usual care, according to a featured science research presentation today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Study identifies a subset of melanoma patients with very low risk of death

Although melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease.

7 Nov 2022

Paxlovid antiviral therapy reduces risk of long COVID

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].

7 Nov 2022

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of its large U.S. Family Heart DatabaseTM showing significant disparities exist in the treatment of familial hypercholesterolemia (FH) among racial groups, and by income and education levels.

7 Nov 2022

Viral whole genome study in the United States identifies ORF-disrupting mutations in monkeypox virus

Researchers used whole genome sequencing to evaluate monkeypox virus samples from Washington and Ohio states in the United States and identified 25 samples with open reading frame (ORF)-disrupting mutations.

7 Nov 2022

Open bypass surgery results in better outcomes for specific patients with severe form of peripheral artery disease

Performing open bypass surgery to restore circulation for people with a severe form of peripheral artery disease (PAD) – a condition that limits blood flow to the legs and feet – resulted in better outcomes for specific patients compared to a less-invasive procedure, a National Institutes of Health-supported clinical research trial has found.

7 Nov 2022

Psilocybin could be a promising therapeutic strategy for people with treatment-resistant depression

Researchers at Trinity College Dublin have participated in the largest and most rigorous clinical trial to date of psilocybin (a psychoactive ingredient in magic mushrooms), pointing to the possibility that COMP360 psilocybin with psychological support could be a beneficial therapeutic strategy for people with treatment-resistant depression (TRD).

7 Nov 2022

Evaluating dual direct-acting antivirals against persistent COVID-19

Researchers assessed the efficiency of dual direct-acting antivirals in treating persistent coronavirus disease 2019 (COVID-19).

7 Nov 2022

New study provides more clarity about giving steroids during pediatric open-heart surgery

For more than four decades, doctors have been split on whether giving steroids during a pediatric open-heart surgery could be helpful for post-operative recovery.

6 Nov 2022

Novel drug lowers triglycerides, does not reduce cardiovascular events

Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice.

6 Nov 2022

MicroRNA can be used as a biomarker to predict breast cancer recurrence and mortality, study says

MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, according to study results published online ahead of print in the Journal of the American College of Surgeons.

6 Nov 2022

$Hypofractionated radiotherapy for patients with soft tissue sarcomas can be a safe, effective alternative to standard of care$

Hypofractionated radiotherapy for patients with soft tissue sarcomas can be a safe, effective alternative to standard of care

Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparable tumor control and no increased risk of major complications in wound healing, according to researchers at The University of Texas MD Anderson Cancer Center.

6 Nov 2022

Endocrine Society rebukes Florida Board of Medicine's decision to ban gender-affirming care

The Endocrine Society rebukes the Florida Board of Medicine's decision to ban gender-affirming care for transgender and gender-diverse teenagers.

6 Nov 2022

UAB researchers report lack of predictability for fecal microbial transplants without prior antibiotic therapy

A fecal microbial transplant - giving a recipient fecal matter from a donor to change the recipient's gut microbial community in the colon - has been a successful last resort therapy for people with recurrent Clostridium difficile infection after multiple rounds of suppressive antibiotics have eliminated the recipient microbial community.

4 Nov 2022

Researchers identify therapies for multiple myeloma patients whose cancer relapses after CAR-T

Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back afterwards.

4 Nov 2022

Developing art and creativity to help fight cancer

Developing art and creativity to improve the effectiveness and delivery of healthcare. From narrative medicine to the disclosure of one's medical records on the net: how "open sourcing" feelings and fears can help fight cancer and reshape the concept of "cure".

4 Nov 2022

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System.

From Beckman Coulter Life Sciences 4 Nov 2022

Charles River Laboratories: New Center Expands Cell and Gene Therapy Capabilities

In this interview, Niall Dinwoodie, Executive Director for Gene Therapy for Charles River in Europe discusses the opening of their new HQ Plasmid Center of Excellence at Alderley Park.

From Charles Rivers Laboratories Cell and Gene Therapy 4 Nov 2022

Therapy News and Research

National study sheds light on how to more effectively treat atrial fibrillation

Study helps to justify the use of Ayres Sensory Integration as a tool for autistic children

High-intensity treatment strategy for heart failure reduces the risk of death or hospital readmission

Study identifies a subset of melanoma patients with very low risk of death

Paxlovid antiviral therapy reduces risk of long COVID

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

Viral whole genome study in the United States identifies ORF-disrupting mutations in monkeypox virus

Open bypass surgery results in better outcomes for specific patients with severe form of peripheral artery disease

Psilocybin could be a promising therapeutic strategy for people with treatment-resistant depression

Evaluating dual direct-acting antivirals against persistent COVID-19

New study provides more clarity about giving steroids during pediatric open-heart surgery

Novel drug lowers triglycerides, does not reduce cardiovascular events

MicroRNA can be used as a biomarker to predict breast cancer recurrence and mortality, study says

Hypofractionated radiotherapy for patients with soft tissue sarcomas can be a safe, effective alternative to standard of care

Endocrine Society rebukes Florida Board of Medicine's decision to ban gender-affirming care

UAB researchers report lack of predictability for fecal microbial transplants without prior antibiotic therapy

Researchers identify therapies for multiple myeloma patients whose cancer relapses after CAR-T

Developing art and creativity to help fight cancer

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

Charles River Laboratories: New Center Expands Cell and Gene Therapy Capabilities

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News